Grace Life-tech Holdings Limited (2112) AI Stock Analysis

1 Followers

Grace Life-tech Holdings Limited

(HKEX:2112)

Select Model

Rating:39Underperform

Price Target:HKD 0.02▼(-4.00% Downside)

Action:reiterated

Date:11/12/26

Poor financial performance with persistent losses and negative equity is the dominant factor. Weak technical momentum and unfavorable valuation metrics further pressure the low score.

Positive Factors

Positive Gross MarginA positive gross margin shows the company retains some economic value after direct costs, providing a foundation for improvement if revenue stabilizes. However, operating losses remain substantial, so this benefit currently does not offset the broader cost burden or establish profitability.

Negative Factors

Persistent UnprofitabilitySix consecutive years of net losses demonstrate that the existing business model has not converted operations into sustainable earnings. Continued losses can consume financial resources, restrict reinvestment, and make recovery dependent on a meaningful improvement in revenue or operating cost discipline.

Grace Life-tech Holdings Limited (2112) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 31.50M
Dividend Yield: ―
Average Volume (3M): 870.70K
Price to Earnings (P/E): -0.2
Beta (1Y): 0.53
Revenue Growth: -45.65%
EPS Growth: 29.13%
Country: Hong Kong
Employees: 46
Sector: Basic Materials
Sector Strength: 61
Industry: Industrial - Distribution

Grace Life-tech Holdings Limited Business Overview & Revenue Model

Company Description

Grace Life-tech Holdings Limited, an investment holding company, engages in the research, development, and application of plant stem cell technology. It is also involved in the provision of health solutions and product sales in Hong Kong, the People’...

Grace Life-tech Holdings Limited Financial Statement Overview

Summary

Persistent losses, declining revenue, negative equity, high debt, and ongoing cash burn indicate severe financial distress.

Income Statement

10Very Negative

Balance Sheet

5Very Negative

Cash Flow

15Very Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	8.78M	13.06M	13.76M	27.25M	32.35M	23.98M
Gross Profit	1.18M	1.48M	2.17M	2.85M	2.54M	164.00K
EBITDA	-8.00M	-7.50M	-30.49M	-23.74M	-42.55M	-44.21M
Net Income	-27.50M	-15.44M	-48.13M	-39.57M	-55.74M	-57.01M
Balance Sheet
Total Assets	77.60M	75.50M	79.80M	108.95M	133.56M	173.13M
Cash, Cash Equivalents and Short-Term Investments	129.98K	358.95K	255.00K	135.00K	187.00K	1.19M
Total Debt	161.26M	148.27M	193.26M	121.04M	171.57M	166.50M
Total Liabilities	271.23M	257.10M	247.29M	228.85M	213.88M	197.41M
Stockholders Equity	-193.43M	-181.42M	-167.40M	-119.90M	-80.32M	-24.27M
Cash Flow
Free Cash Flow	-4.43M	-372.55K	-78.00K	-53.00K	-1.01M	1.10M
Operating Cash Flow	-4.43M	-372.55K	-75.00K	-27.00K	-1.00M	1.41M
Investing Cash Flow	0	0	-3,000	-26.00K	-2,000	-303.00K
Financing Cash Flow	4.48M	488.72K	193.00K	0	0	-12.00K

Grace Life-tech Holdings Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price0.03

Price Trends

50DMA0.04Negative

100DMA0.04Negative

200DMA0.05Negative

Market Momentum

MACD-0.00Positive

RSI7.59Positive

STOCH1.21Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2112, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 7.59 is Positive, neither overbought nor oversold. The STOCH value of 1.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2112.

Grace Life-tech Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

HK:2112 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
HK:0609	45Neutral	HKD 847.67M	13.98	2.08%	3.19%	16.60%	-12.13%
HK:0301	42Neutral	HKD 3.78B	-200.56	-8.09%	―	3.15%	50.74%
HK:8189	40Underperform	HKD 260.34M	-10.32	-634.56%	―	53.32%	-122.35%
HK:2112	39Underperform	HKD 37.50M	-0.17	14.68%	―	-45.65%	29.13%

* Basic Materials Sector Average

Performance Comparison

HK:2112 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:2112	Grace Life-tech Holdings Limited	0.03	-0.04	-59.02%
HK:8189	Tianjin TEDA Biomedical Engineering Co. Ltd. Class H	0.12	-0.26	-68.68%
HK:0609	Tiande Chemical Holdings Limited	0.94	-0.45	-32.34%
HK:0301	SANVO Fine Chemicals Group Limited	7.93	6.43	428.67%
HK:0660	Wai Chun Bio-Technology Ltd.	0.43	0.22	103.79%
HK:2565	PegBio Co., Ltd. Class H	3.38	-57.33	-94.44%

Grace Life-tech Holdings Limited Corporate Events

Grace Life-tech Publishes 2026 Interim Results Amid Ongoing Restructuring

Aug 31, 2026

Grace Life-tech Holdings Limited has released its unaudited interim results for the six months ended 30 June 2026, fulfilling Hong Kong listing requirements despite being under restructuring with joint provisional liquidators in place. The interim re...

Grace Life-tech Sets August Board Meeting to Approve Interim Results and Consider Dividend

Aug 18, 2026

Grace Life-tech Holdings Limited has scheduled a board meeting for 31 August 2026 to review and approve the interim results of the company and its subsidiaries for the six months ended 30 June 2026. The board will also consider the declaration of an...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026

Grace Life-tech Holdings Limited AI Stock Analysis